Last updated 8 days ago
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
6000 patients around the world
Available in Argentina, Mexico, United States, Brazil, Spain
Eli Lilly and Company
76Research sites
6000Patients around the world
This study is for people with
Breast Cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Centro Médico Privado CEMAIC - Córdoba
Recruiting
Instituto San Marcos Investigación - San Juan
Recruiting
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
Centro Polivalente de Asistencia e Investigación Clínica - CER San Juan
Recruiting
CIPREC Centro de Investigación y Prevención Cardiovascular - CABA
Recruiting
Fundación Cori para la Investigación y Prevención del Cáncer - La Rioja
Recruiting
Clínica Adventista Belgrano - CABA - Buenos Aires
Recruiting
Instituto de Investigaciones Clínicas Mar del Plata
Recruiting
Centro de Oncología e Investigación Buenos Aires COIBA
Recruiting
Go Centro Médico San Nicolás
Recruiting
StudyEMBER-4
SponsorEli Lilly and Company
Study typeInterventional
Conditions
Breast Cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05514054
